HUMAN BRAIN MAPPING:海洛因成瘾者截断后额-边缘系统神经回路可部分恢复

2022-04-01 MedSci原创 MedSci原创

海洛因成瘾者截断后受损的额-边缘系统神经回路可以部分恢复,这将支持认知能力的提高和渴望的减少。

海洛因成瘾者(HUs)有大脑结构和功能改变。海洛因成瘾是一种复发性脑障碍,几十年来一直是公众和社会关注的一个主要问题。 海洛因作为一种阿片受体激动剂,与GABA能神经元上的μ-阿片受体结合,抑制GABA的抑制作用,并通过增加多巴胺的释放导致奖赏效应的提升。 长期使用海洛因会导致DA系统功能障碍,尤其是前额叶皮层(PFC)和纹状体。然而,人们对长期戒断海洛因后大脑恢复的可能性知之甚少

Jun Liu等在HUMAN BRAIN MAPPING杂志发表研究文章,调查海洛因成瘾者持久性截断后大脑是否可能恢复。

该研究共有108名海洛因成瘾者完成了结构和功能扫描,其中61人完成了8个月的随访扫描。收集所有参与者的静息状态数据和3D-T1 MR图像,首先在基线(HU1)时,然后在8个月后再次收集(HU2)。认知功能和渴望分别由Trail Making Test-A (TMT-A)和视觉模拟渴望量表测量。分析比较基线和随访时皮层厚度和静息状态功能连接(resting-state functional connectivity, RSFC)差异,得出神经影像学与行为变化之间的相关性。

HU1和HU2的结构差异。HU1:基线时的海洛因戒断使用者。HU2: 8个月随访时海洛因戒断者。

与HU1相比,HU2显示双侧SFG皮质厚度显著增加,左侧距状回、左侧中央后回、左侧梭状回、左侧中央旁回、双侧颞上回、双侧缘上回、右侧中央前回皮质厚度显著降低。

与基线(HU1)相比,HU2认知改善(TMT-A时间缩短),渴望减少,并且在HU2时双侧额上回(SFG)的皮层厚度显著高于HU1

与HU1相比,HU2的左侧SFG-双侧额下回(FWE校正)之间RSFC增加

HU2时,左SFG与额下回(IFG)、岛叶和伏隔核的RSFC增加,右SFG与IFG、岛叶和眶额皮层(OFC)的RSFC增加

TMT-A时间的变化与左侧SFG与双侧IFG、双侧尾状核、右侧岛叶的RSFC变化呈负相关。

渴望的改变与左侧OFC-双侧OFC的RSFC变化呈负相关。

RSFC变化与TMT-A评分的变化呈负相关

在HUs中,渴望得分的变化与RSFC变化呈负相关

 

该研究发现在持续性截断后,HUs的认知功能改善,渴望减少,以及SFG皮层厚度增加和SFG RSFC增强。行为改变和神经成像之间的联系进一步暗示了海洛因成瘾者截断后大脑恢复的可能性。

该研究结果表明,海洛因成瘾者截断后受损的额-边缘系统神经回路可以部分恢复,这将支持认知能力的提高和渴望的减少。没有发现右侧SFG RSFC与改善认知功能或减少渴望之间的相关性,这可能是由于大脑的不对称。

 

原文出处

Recovery of superior frontal gyrus cortical thickness and resting-state functional connectivity in abstinent heroin users after 8 months of follow-up

Wenhan Yang,Min Zhang,Fei Tang,Yanyao Du,Li Fan,Jing Luo,Cui Yan,Shicong Wang,Jun Zhang,Kai Yuan,Jun Liu.First published: 24 March 2022 https://doi.org/10.1002/hbm.25841

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1742104, encodeId=43061e42104c8, content=<a href='/topic/show?id=cbcde425156' target=_blank style='color:#2F92EE;'>#神经回路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74251, encryptionId=cbcde425156, topicName=神经回路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Mar 12 16:26:08 CST 2023, time=2023-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947669, encodeId=b639194e669e3, content=<a href='/topic/show?id=974d112896d' target=_blank style='color:#2F92EE;'>#mapping#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11289, encryptionId=974d112896d, topicName=mapping)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Wed Sep 28 22:26:08 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1940464, encodeId=c76c1940464e8, content=<a href='/topic/show?id=0de4919efc' target=_blank style='color:#2F92EE;'>#human#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9197, encryptionId=0de4919efc, topicName=human)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Mon May 23 16:26:08 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523501, encodeId=1a3d1523501fc, content=<a href='/topic/show?id=510865640d9' target=_blank style='color:#2F92EE;'>#海洛因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65640, encryptionId=510865640d9, topicName=海洛因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27e211527640, createdName=xuqianhua, createdTime=Wed Mar 30 06:26:08 CST 2022, time=2022-03-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1742104, encodeId=43061e42104c8, content=<a href='/topic/show?id=cbcde425156' target=_blank style='color:#2F92EE;'>#神经回路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74251, encryptionId=cbcde425156, topicName=神经回路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Mar 12 16:26:08 CST 2023, time=2023-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947669, encodeId=b639194e669e3, content=<a href='/topic/show?id=974d112896d' target=_blank style='color:#2F92EE;'>#mapping#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11289, encryptionId=974d112896d, topicName=mapping)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Wed Sep 28 22:26:08 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1940464, encodeId=c76c1940464e8, content=<a href='/topic/show?id=0de4919efc' target=_blank style='color:#2F92EE;'>#human#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9197, encryptionId=0de4919efc, topicName=human)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Mon May 23 16:26:08 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523501, encodeId=1a3d1523501fc, content=<a href='/topic/show?id=510865640d9' target=_blank style='color:#2F92EE;'>#海洛因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65640, encryptionId=510865640d9, topicName=海洛因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27e211527640, createdName=xuqianhua, createdTime=Wed Mar 30 06:26:08 CST 2022, time=2022-03-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1742104, encodeId=43061e42104c8, content=<a href='/topic/show?id=cbcde425156' target=_blank style='color:#2F92EE;'>#神经回路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74251, encryptionId=cbcde425156, topicName=神经回路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Mar 12 16:26:08 CST 2023, time=2023-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947669, encodeId=b639194e669e3, content=<a href='/topic/show?id=974d112896d' target=_blank style='color:#2F92EE;'>#mapping#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11289, encryptionId=974d112896d, topicName=mapping)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Wed Sep 28 22:26:08 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1940464, encodeId=c76c1940464e8, content=<a href='/topic/show?id=0de4919efc' target=_blank style='color:#2F92EE;'>#human#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9197, encryptionId=0de4919efc, topicName=human)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Mon May 23 16:26:08 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523501, encodeId=1a3d1523501fc, content=<a href='/topic/show?id=510865640d9' target=_blank style='color:#2F92EE;'>#海洛因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65640, encryptionId=510865640d9, topicName=海洛因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27e211527640, createdName=xuqianhua, createdTime=Wed Mar 30 06:26:08 CST 2022, time=2022-03-30, status=1, ipAttribution=)]
    2022-05-23 tamgche
  4. [GetPortalCommentsPageByObjectIdResponse(id=1742104, encodeId=43061e42104c8, content=<a href='/topic/show?id=cbcde425156' target=_blank style='color:#2F92EE;'>#神经回路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74251, encryptionId=cbcde425156, topicName=神经回路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Mar 12 16:26:08 CST 2023, time=2023-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947669, encodeId=b639194e669e3, content=<a href='/topic/show?id=974d112896d' target=_blank style='color:#2F92EE;'>#mapping#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11289, encryptionId=974d112896d, topicName=mapping)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Wed Sep 28 22:26:08 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1940464, encodeId=c76c1940464e8, content=<a href='/topic/show?id=0de4919efc' target=_blank style='color:#2F92EE;'>#human#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9197, encryptionId=0de4919efc, topicName=human)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Mon May 23 16:26:08 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523501, encodeId=1a3d1523501fc, content=<a href='/topic/show?id=510865640d9' target=_blank style='color:#2F92EE;'>#海洛因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65640, encryptionId=510865640d9, topicName=海洛因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27e211527640, createdName=xuqianhua, createdTime=Wed Mar 30 06:26:08 CST 2022, time=2022-03-30, status=1, ipAttribution=)]

相关资讯

Biol Psychiatry:治疗海洛因成瘾的新靶点

根据西奈山医学院在《生物精神病学》杂志上的最新报道,使用海洛因的年限越长,高度乙酰化的水平越高。这项研究首次提供了直接证据证明:鸦片导致人类大脑表观遗传学改变,包括成瘾性药物如若无人之地般改变部分DNA的开合,从而控制有关成瘾性基因的打开或关闭。

美国类鸦片药物泛滥 致每天逾90人丧生

据美国媒体报道,新的研究显示,对类鸦片药物的滥用可能在显著降低在美国工作的全盛工作年龄段的人数。此前曾经有报道称,每天有91名美国人死于过量服用类鸦片药物。

为什么芬太尼比海洛因更致命

阿片类危机持续恶化,部分原因是新型毒品不断流入街头。海洛因的合成表亲,芬太尼,是罪魁祸首之一。这是致命的,因为它比海洛因强得多,如上图所示,拍摄于新罕布什尔州警察法医实验室。左边是一个致命剂量的海洛因,相当于约30毫克; 右侧是3毫克剂量的芬太尼,足以杀死中等身材的成年男性。据美国疾病控制与预防中心(Centers for Disease Control and Prevention)称,芬太尼的

MOL PHARM:新疫苗既可以治疗海洛因成瘾,也可以阻止药物过量

斯克里普斯研究所(TSRI)的科学家在设计安全有效的疫苗方面取得了重大的里程碑,该疫苗既可以治疗海洛因成瘾,也可以阻止致命的药物过量。他们今天发表在“分子药剂学”杂志上的研究表明,在动物模型中安全的新型抗海洛因制剂如何在室温下至少保持30天。疫苗即将准备进行人体测试。

CLIN CHEM:利用单指纹技术无创检测可卡因和海洛因使用情况

最近发表的研究探索了利用指纹来确认药物使用的可能性,但是还没有排除指尖环境的污染。在本研究中,研究人员探索了从单个指纹建立药物测试环境临界值的可能性。 在50名非药物使用者洗手前后收集指纹样本(n = 100)以建立单独的环境临界值和对可卡因,苯甲酰芽子碱,海洛因和6-单乙酰吗啡的测试方案。与毒品使用者握手后,通过测试无药物志愿者的指纹来测定临界值。此外,本研究还收集并分析了经证实服用过可卡

重磅!我国科学家发现海洛因成瘾可改变大脑皮层可塑性

6.26 国际禁毒日又要到了,我们都知道毒品成瘾难以戒除。成瘾的过程被认为是毒品“绑架”了大脑内正常奖赏活动区域(如多巴胺释放)以对成瘾行为进行强化,如同“黑暗学习”。可塑性(大脑结构与功能变化的能力)被认为是大脑对外界环境刺激做出学习性变化的基础,在过去的几十年内已有数百篇文献报道了成瘾药物使用在大脑的边缘系统和奖赏中枢会诱导可塑性变化,而通过深层脑刺激及非侵入性脑刺激等不同手段可以在一定程度上